Variant report

Variant	rs6792636
Chromosome Location	chr3:42533264-42533265
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr3:42529189..42533440-chr3:42542111..42547805,7	MCF-7	breast:

Variant related genes	Relation type
ENSG00000114812	Chromatin interaction

Extended variants
information (count: 4 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:1)

rs_ID	r²[population]
rs6797718	0.80[EUR][1000 genomes];0.97[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv529987	chr3:41921995-42591771	Bivalent Enhancer Weak transcription Flanking Active TSS Strong transcription Enhancers Flanking Bivalent TSS/Enh Active TSS Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
2	nsv1005533	chr3:41953873-42596375	Enhancers Flanking Bivalent TSS/Enh Genic enhancers Weak transcription Flanking Active TSS Strong transcription Bivalent/Poised TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	31 gene(s)	inside rSNPs	diseases
3	esv1804804	chr3:42515186-42582403	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Transcr. at gene 5' and 3' Strong transcription Genic enhancers Bivalent/Poised TSS Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:43 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:42528200-42535400	Enhancers	Primary monocytes fromperipheralblood	blood
2	chr3:42530200-42535200	Enhancers	Placenta	Placenta
3	chr3:42530200-42535600	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr3:42530200-42535600	Enhancers	Lung	lung
5	chr3:42530800-42535000	Enhancers	Primary B cells from cord blood	blood
6	chr3:42530800-42535000	Enhancers	Primary B cells from peripheral blood	blood
7	chr3:42531000-42534400	Enhancers	Breast Myoepithelial Primary Cells	Breast
8	chr3:42531400-42533600	Weak transcription	Adipose Nuclei	Adipose
9	chr3:42532000-42533400	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
10	chr3:42532000-42533800	Weak transcription	Right Ventricle	heart
11	chr3:42532200-42533600	Weak transcription	Fetal Lung	lung
12	chr3:42532200-42533600	Weak transcription	Spleen	Spleen
13	chr3:42532200-42533800	Weak transcription	Duodenum Mucosa	Duodenum
14	chr3:42532200-42533800	Weak transcription	Fetal Muscle Leg	muscle
15	chr3:42532200-42534000	Weak transcription	Colon Smooth Muscle	Colon
16	chr3:42532200-42534200	Weak transcription	Right Atrium	heart
17	chr3:42532200-42534400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
18	chr3:42532200-42534800	Weak transcription	Skeletal Muscle Male	skeletal muscle
19	chr3:42532200-42538800	Weak transcription	H9 Cell Line	embryonic stem cell
20	chr3:42532400-42533600	Weak transcription	Aorta	Aorta
21	chr3:42532400-42533800	Weak transcription	Gastric	stomach
22	chr3:42532400-42534600	Weak transcription	Skeletal Muscle Female	skeletal muscle
23	chr3:42532400-42535600	Enhancers	GM12878-XiMat	blood
24	chr3:42532600-42533600	Weak transcription	Stomach Mucosa	stomach
25	chr3:42532600-42533600	Weak transcription	HUVEC	blood vessel
26	chr3:42532600-42533800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr3:42532600-42533800	Weak transcription	Left Ventricle	heart
28	chr3:42532600-42533800	Weak transcription	Rectal Mucosa Donor 29	rectum
29	chr3:42532600-42534000	Weak transcription	Pancreas	Pancrea
30	chr3:42532600-42535400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
31	chr3:42532600-42537600	Weak transcription	Hela-S3	cervix
32	chr3:42532600-42537800	Weak transcription	HUES48 Cell Line	embryonic stem cell
33	chr3:42532600-42538000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
34	chr3:42532600-42538000	Weak transcription	A549	lung
35	chr3:42532600-42538400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr3:42532600-42538400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
37	chr3:42532600-42538600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr3:42532600-42538800	Weak transcription	Esophagus	oesophagus
39	chr3:42532800-42534200	Weak transcription	Fetal Heart	heart
40	chr3:42532800-42537800	Weak transcription	iPS-18 Cell Line	embryonic stem cell
41	chr3:42533200-42534400	Enhancers	Primary neutrophils fromperipheralblood	blood
42	chr3:42533200-42534600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr3:42533200-42534600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links